NEW YORK (GenomeWeb News) – Roche Diagnostics said today that it has granted a non-exclusive license of its melting curve analysis technology to Agilent Technologies
 
Under the agreement, Agilent has acquired the rights to use, develop, and sell products that are based on Roche’s melting curve analysis technique, which is used in analyzing DNA in the PCR process.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.